不确定潜能的克隆性造血与遗传易感性在年龄相关性黄斑变性发病中的协同作用:一项队列研究
不确定潜能的克隆性造血(CHIP)与AMD发病风险升高14%独立相关(HR 1.14;95%CI 1.03,1.26;CHIP合并高多基因风险评分(PRS)者风险增加3.26倍(95%CI 2.75,3.86;
要点
- CHIP是AMD发病的独立风险因素(HR 1.14;95%CI 1.03,1.26)。
- CHIP合并高PRS者AMD风险增加3.26倍,存在相加交互作用。
- DNMT3A突变合并高PRS者风险最高(HR 3.69;95%CI 2.58,3.96)。
核心结论
- CHIP是AMD发病的独立风险因素,且与高遗传易感性存在协同交互作用,在老年人中效应最强。
主要发现
- 上述协同效应在老年人中更为显著。
关键数值与推荐
- CHIP定义为白血病相关驱动基因中体细胞突变且变异等位基因频率≥2%。
- AMD PRS基于已确立的遗传变异计算。
- 采用Cox比例风险模型评估CHIP和PRS与AMD发病的独立及联合关联。
临床怎么用
- 研究提示可将体细胞突变状态纳入AMD风险分层体系,尤其在老年人群中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: While inherited genetics strongly influence AMD risk, clonal hematopoiesis of indeterminate potential (CHIP), an age-related condition driven by somatic mutations and inflammation, is a novel, biologically plausible risk factor. Prospective evidence exploring their interplay with AMD incidence is lacking. DESIGN: Prospective cohort study. PARTICIPANTS: We conducted a prospective cohort study among 395 505 participants from the UK Biobank. METHODS: CHIP was defined by somatic mutations (variant allele fraction ≥ 2%) in leukemia-associated driver genes from blood-derived exome sequencing. A polygenic risk score (PRS) for AMD was calculated using established genetic variants. We used Cox proportional hazards models to assess the independent and joint associations of CHIP and PRS with incident AMD. MAIN OUTCOME MEASURES: Age-related macular degeneration. RESULTS: During a median follow-up of 15.5 years, we documented 7178 incident AMD cases. CHIP was associated with a 14% higher risk of incident AMD (HR: 1.14; 95% CI: 1.03, 1.26; P = .009). Gene-specific analyses showed significant associations for mutations in DNMT3A (HR: 1.20; 95% CI: 1.06, 1.36; P = .005), spliceosome genes (HR: 1.72; 95% CI: 1.02, 2.97; P = .042), and DNA damage repair genes (HR: 1.68; 95% CI: 1.06, 2.67; P = .028). A high AMD PRS was also associated with AMD risk. Participants with both any CHIP and a high PRS had a 3.26-fold higher risk (95% CI: 2.75, 3.86; P < .001) compared to those with neither, with evidence of additive interaction (relative excess risk due to interaction [RERI] = 0.60; 95% CI: 0.07, 1.20). The joint effect was also strongest for DNMT3A mutation carriers with high PRS (HR: 3.69; 95% CI: 2.58, 3.96; P < .001; RERI = 0.34; 95% CI: 0.04, 1.12). These synergistic effects were more pronounced in older adults. CONCLUSION: CHIP was an independent risk factor for incident AMD. The risk is amplified in individuals with high genetic susceptibility, suggesting a synergistic interplay between inherited genetic risk and somatic clonal expansion in AMD pathogenesis, with the strongest effects observed in older adults. These findings provide a rationale for future efforts to integrate somatic mutation status into risk stratification paradigms for AMD, especially among the elderly.
引用
- Li FR, Peng MJ, Lin KQ, et al. Clonal Hematopoiesis of Indeterminate Potential and Genetic Susceptibility in Incident Age-Related Macular Degeneration: A Cohort Study. Am J Ophthalmol. 2026. PMID: 42419444. doi:10.1016/j.ajo.2026.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。